Diamedica Therapeutics (DMAC) Ownership - Who Owns Diamedica Therapeutics?

Q: What percentage of Diamedica Therapeutics (DMAC) stock is held by retail investors?

According to the latest TipRanks data, approximately 51.36% of Diamedica Therapeutics (DMAC) stock is held by retail investors.

Q: Who owns the most shares of Diamedica Therapeutics (DMAC)?

JAN STAHLBERG owns the most shares of Diamedica Therapeutics (DMAC).

Q: What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

573 Followers

Diamedica Therapeutics (DMAC) Ownership Overview

42.47% Insiders

2.80% Mutual Funds

3.37% ETFs

51.36% Public Companies and

Individual Investors

The ownership structure of Diamedica Therapeutics (DMAC) stock is a mix of institutional, retail, and individual investors. , 42.47% is owned by Insiders, and 51.36% is owned by Public Companies and Individual Investors.

The ownership structure of Diamedica Therapeutics (DMAC) stock is a mix of institutional, retail, and individual investors. Approximately 6.17% of the company’s stock is owned by Institutional Investors, 42.47% is owned by Insiders, and 51.36% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Dec 08, 2025	Jan Stahlberg	xxxxxxxxxxxxx	$7624976
Sep 04, 2025	Jan Stahlberg	xxxxxxxxxxxxx	$5951087
Jul 25, 2025	Jan Stahlberg	xxxxxxxxxxxxx	$5400000
Jul 25, 2025	Richard Ii Jacinto	xxxxxxxxxxxxx	$1400000

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
8,825,742	Insider	16.38%	49,865,442
8,383,577	Insider	15.56%	47,367,210
4,958,823	Insider	9.20%	28,017,350
1,153,992	Institution	2.14%	6,520,055
563,791	Institution	1.05%	3,185,419
445,230	Insider	0.83%	2,515,550
356,031	Institution	0.66%	2,011,575
333,456	Institution	0.62%	1,884,026
303,940	Institution	0.56%	1,717,261
201,543	Institution	0.37%	1,138,718

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
356,031	Institution	0.66%	2,011,575
333,456	Institution	0.62%	1,884,026
303,940	Institution	0.56%	1,717,261
201,543	Institution	0.37%	1,138,718
96,880	Institution	0.18%	547,372
92,730	Institution	0.17%	523,925
40,668	Institution	0.08%	229,774
17,618	Institution	0.03%	99,542
11,200	Institution	0.02%	63,280
9,900	Institution	0.02%	55,935

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	796,375	Institution	1.48%	4,499,519
Vanguard Extended Market ETF	356,765	Institution	0.66%	2,158,428
iShares Russell 2000 Growth ETF	279,932	Institution	0.52%	1,581,616
Vanguard Russell 2000 ETF	173,118	Institution	0.32%	1,047,364
iShares Micro-Cap ETF	88,703	Institution	0.16%	501,172
Vanguard Russell 2000 Growth ETF	31,501	Institution	0.06%	190,581
Global X Russell 2000 ETF	14,992	Institution	0.03%	81,856
Invesco Russell 2000 UCITS ETF	3,258	Institution	<0.01%	17,793
Vanguard Russell 3000 ETF	2,407	Institution	<0.01%	14,562
ProShares Russell 2000 High Income ETF	1,629	Institution	<0.01%	9,204

FAQ

Who Owns Diamedica Therapeutics (DMAC)?

Currently, no data Available

What percentage of Diamedica Therapeutics (DMAC) stock is held by institutional investors?

Currently, no data Available

What percentage of Diamedica Therapeutics (DMAC) stock is held by retail investors?

According to the latest TipRanks data, approximately 51.36% of Diamedica Therapeutics (DMAC) stock is held by retail investors.

Who owns the most shares of Diamedica Therapeutics (DMAC)?

JAN STAHLBERG owns the most shares of Diamedica Therapeutics (DMAC).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.